4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0000950170-24-109449
Chief Executive Officer sold 19,771 shares at $5.98 ($118,231)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Barrow Robert Chief Executive Officer | 2024-09-25 | Sale 10b5-1 | −19,771 | $5.98 | $118,231 | 545,772 | D |
| Open-market sales · 19,771 sh · avg $5.98 · $118,231 | |||||||
Loading xslF345X05/ownership.xml…